Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GHRS — GH Research PLC SEC Filings | FilingIndex

GHRSNasdaq

GH Research PLC

Pharmaceutical Preparations · L2 · CIK 1855129

GH Research PLC develops mebufotenin therapies for treatment-resistant depression

+ Watch View on EDGAR ↗

$1.45B

Market cap

$26.88

Last close

-5.7%

1D

+13.8%

5D

213K

Volume

Price · last 40 sessions+23.9%

May 4L $19.98 · H $28.49Jun 30

120

Total filings

Jun 26, 2026

Last filing

12/31

Fiscal year end

All 6-K · 102 SC 13G · 8 20-F · 5 424B5 · 4 424B4 · 1

SC 13GGH RESEARCH PLCFeb 16, 2024 SC 13GGH RESEARCH PLCFeb 14, 2024 SC 13GSC 13GMay 27, 2022 SC 13GTHE SCHEDULE 13GFeb 14, 2022 SC 13GFORM SC 13GFeb 9, 2022 SC 13G

Similar companies

Comparable business profile · signals at a glance

DFTXDefinium Therapeutics, Inc.🔥$2.7B+1.1%ATAIAtaiBeckley Inc.$1.4B-1.7%CMPSCOMPASS Pathways plc$1.6B-6.1%ANROAlto Neuroscience, Inc.$753.5M-6.0%DRUGBRIGHT MINDS BIOSCIENCES INC.

FORM SC 13G

Feb 9, 2022

SC 13GSC 13GFeb 9, 2022

SC 13GSC 13GJul 9, 2021

$598.0M

+1.5%

GANXGain Therapeutics, Inc.$71.7M+2.5%